PDIA3 and PDIA6 gene expression as an aggressiveness marker in primary ductal breast cancer

Genetics and Molecular Research

Volumn 14, Issue 2, 2015, Pages 6960-6967

  Ramos, F S ^a   Serino, L T R ^a   Carvalho, C M S ^a   Lima, R S ^b   Urban, C A ^b   Cavalli, I J ^a   Ribeiro, E M S F ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b HOSPITAL NOSSA SENHORA DAS GRAÇAS   (Brazil)

Author keywords

Metastasis; Protein disulfide isomerases; Stress response; Tumorigenesis

Indexed keywords

MESSENGER RNA; ESTROGEN RECEPTOR; PDIA3 PROTEIN, HUMAN; PDIA6 PROTEIN, HUMAN; PROGESTERONE RECEPTOR; PROTEIN DISULFIDE ISOMERASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GRADING; CANCER GROWTH; CLINICAL ARTICLE; ENDOPLASMIC RETICULUM STRESS; GENE; GENE EXPRESSION; HUMAN; LYMPH NODE METASTASIS; PDIA3 GENE; PDIA6 GENE; PREVALENCE; PROTEIN FOLDING; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; TUMOR INVASION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; PROTEIN DISULFIDE-ISOMERASES; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 84933576003     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2015.June.26.4     Document Type: Article

References (20)

1. Ayshamgul H, Ma H, Ilyar S, Zhang LW, et al. (2011). Association of defective HLA-I expression with antigen processing machinery and their association with clinicopathological characteristics in Kazak patients with esophageal cancer. Chin. Med. J. 124: 341-346.
2. Bernardini M, Lee CH, Beheshti B, Prasad M, et al. (2005). High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer. Neoplasia7: 603-613.
3. Bustin SA, Benes V, Garson JA, Hellemans J, et al. (2009). The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem.55: 611-622.
4. Chichiarelli S, Ferraro A, Altieri F, Eufemi M, et al. (2007). The stress protein ERp57/GRP58 binds specific DNA sequences in HeLa cells. J. Cell Physiol.210: 343-351.
5. Chung H, Cho H, Perry C, Song J, et al. (2013). Downregulation of ERp57 expression is associated with poor prognosis in early-stage cervical cancer. Biomarkers18: 573-579.
6. De Marco F, Bucaj E, Foppoli C, Fiorini A, et al. (2012). Oxidative stress in HPV-driven viral carcinogenesis: redox proteomics analysis of HPV-16 dysplastic and neoplastic tissues. PLoS One7: e34366.
7. Gaucci E, Altieri F, Turano C and Chichiarelli S (2013). The protein Erp57 contributes to EGF receptor signaling and internalization in MDA-MB-468 breast cancer cells. J. Cell. Biochem. 114: 2461-2470.
8. Kaiser BK, Yim D, Chow IT, Gonzalez S, et al. (2007). Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands. Nature482-487.
9. Khan MM, Nomura T, Chiba T, Tanaka K, et al. (2014). The fusion oncoprotein PML-RARalpha induces endoplasmic reticulum (ER)-associated degradation of N-CoR and ER stress. J. Biol. Chem.279: 11814-118524.
10. Krynetskaia NF, Phadke MS, Jadhav SH and Krynetskiy EY (2009). Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage. Mol. Cancer Ther.8: 864-872.
11. Lee HH, Lim CA, Cheong YT, Singh M, et al. (2012). Comparison of protein expression profiles of different stages of lymph nodes metastasis in breast cancer. Int. J. Biol. Sci.8: 353-362.
12. Leys CM, Nomura S, Lafleur BJ, Ferrone S, et al. (2007). Expression and prognostic significance of prothymosin-alpha and ERp57 in human gastric cancer. Surgery141: 41-45.
13. Livak KJ and Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods25: 402-408.
14. Ménoret A, Drew DA, Miyamoto S, Nakanishi M, et al. (2012). Differential proteomics identifies pdia3 as a novel chemoprevention target in human colon cancer cells. Mol. Carcinog.53 (Suppl 1): E11-E22.
15. Müller M, Agaimy A, Zenk J, Ettl T, et al. (2013). The prognostic impact of human leukocyte antigen (HLA) class I antigen abnormalities in salivary gland cancer. A clinicopathological study of 288 cases. Histopathology62: 847-859.
16. Oliveira N, Gomig TB, Milioli HHZ, Urban CA, et al. (2011). Comparative proteomics between ductal and lobular primary breast carcinomas. In: 57th Congresso da Sociedade Brasileira de Genética. Anais do 57° Congresso da SBG, Águas de Lindoia.
17. Pressinotti NC, Klocker H, Schäfer G, Luu VD, et al. (2009). Differential expression of apoptotic genes PDIA3 and MAP3K5 distinguishes between low- and high-risk prostate cancer. Mol. Cancer1: 63-71.
18. Santana-Codina N, Carretero R, Sanz-Pamplona R, Cabrera T, et al. (2013). A transcriptome-proteome integrated network identifies endoplasmic reticulum thiol oxireductase (Erp57) as a hub that mediates bone metastasis. Mol. Cell. Proteomics12: 2111-2125.
19. Wilkinson B and Gilbert HF (2004). Protein disulfide isomerase. Biochim. Biophys. Acta1: 35-44.
20. Xiong Y, Manevich Y, Tew KD and Townsend DM (2012). S-Glutathionylation of protein disulfide isomerase regulates estrogen receptor a stability and function. Int. J. Cell. Biol.2012: 273549.